Flow Cytometry – News and Features

An overabundance of cloned white blood cells hampers the immune system and increases the risk of melanoma, a new study finds.

New research may provide a new biological target for immunotherapies designed to destroy spreading cancer cells that are often markers for worsening disease.

In this interview, Xiaobo Wang discusses some of the NovoCyte Opteon’s advanced spectral capabilities and how they help to address existing challenges in flow cytometry.

If it’s ever felt like everything in your body is breaking down at once, that might not be your imagination. A new Stanford Medicine study shows that many of our molecules and microorganisms dramatically rise or fall in number during our 40s and 60s.

ACE, a new DNA-powered signal amplification technology, dramatically increases sensitivity of mass cytometry, opening new windows on many biological and pathological processes.

This article explores how recent advances in nanoscale technology are helping researchers to obtain more data with less hands-on time, vastly increasing what they can study and discover about diseases.

New research has honed in on the mechanisms behind cancer cell division after treatment, offering insights into potential new drug targets.

Investigators have uncovered new details about the role of a protein called interferon regulatory factor (IRF1) in cancer progression and treatment response, offering new insight that can potentially help improve the effectiveness of cancer immunotherapy.

An “unconventional” immune response recently identified by scientists is a potential new pathway for developing new vaccines for tuberculosis.

A new study explores how polycystic ovary syndrome (PCOS) impacts the immune system, revealing that immune cell populations were affected across reproductive, metabolic and immunological tissues in different ways.